These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

840 related items for PubMed ID: 18302700

  • 1. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
    Freitag F, Smith T, Mathew N, Rupnow M, Greenberg S, Mao L, Finlayson G, Wright P, Biondi D, AEGIS Investigator Study Group.
    Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
    [Abstract] [Full Text] [Related]

  • 2. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ, AEGIS Investigator Study Group.
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
    Diamond ML, Cady RK, Mao L, Biondi DM, Finlayson G, Greenberg SJ, Wright P.
    Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
    [Abstract] [Full Text] [Related]

  • 4. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG, Finlayson G, Rapoport AM, Elkind AH, Diamond ML, Unger JR, Fisher AC, Armstrong RB, Hulihan JF, Greenberg SJ, AIMS Investigators.
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [Abstract] [Full Text] [Related]

  • 5. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ, Massiou H, Lainez JM, Cabarrocas X.
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [Abstract] [Full Text] [Related]

  • 6. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
    Goadsby PJ.
    Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
    [Abstract] [Full Text] [Related]

  • 7. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC, Gendolla A, Gebert I, Beneke M.
    Headache; 2005 Sep; 45(7):874-82. PubMed ID: 15985104
    [Abstract] [Full Text] [Related]

  • 8. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
    Goadsby PJ, Zanchin G, Geraud G, de Klippel N, Diaz-Insa S, Gobel H, Cunha L, Ivanoff N, Falques M, Fortea J.
    Cephalalgia; 2008 Apr; 28(4):383-91. PubMed ID: 18294251
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC.
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [Abstract] [Full Text] [Related]

  • 10. Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
    Cady RK, Freitag FG, Mathew NT, Elkind AH, Mao L, Fisher AC, Biondi DM, Finlayson G, Greenberg SJ, Hulihan JF.
    Headache; 2009 Mar; 49(3):350-63. PubMed ID: 19220503
    [Abstract] [Full Text] [Related]

  • 11. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 13. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P, Landy S, Richardson M, Ames M.
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [Abstract] [Full Text] [Related]

  • 14. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M, Aschoff J, May A, Charlesworth BR, REALIZE Study Team.
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [Abstract] [Full Text] [Related]

  • 15. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.
    Silberstein SD, Cady RK, Sheftell FD, Almas M, Parsons B, Albert KS.
    Headache; 2007 May; 47(5):673-82. PubMed ID: 17501848
    [Abstract] [Full Text] [Related]

  • 17. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies.
    Silberstein SD, Armellino JJ, Hoffman HD, Battikha JP, Hamelsky SW, Stewart WF, Lipton RB.
    Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417
    [Abstract] [Full Text] [Related]

  • 18. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [Abstract] [Full Text] [Related]

  • 19. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
    Winner P, Linder SL, Lipton RB, Almas M, Parsons B, Pitman V.
    Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
    [Abstract] [Full Text] [Related]

  • 20. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J, García-Moncó C, Roig C, Yusta Izquierdo A, López-Gil A, eMAX Study Group.
    Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.